Health 8 sources·Updated Sep 24, 2026 The U.S. Food and Drug Administration on Thursday, Sept. 24, 2026, approved Eli Lilly’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults…
by Rasmus Cloes, Leibniz Institute for Prevention Research and Epidemiology – BIPS Credit: Unsplash/CC0 Public Domain Type 2 diabetes is increasingly affecting young adults in Germany, with new evidence showing…
Credit: Pixabay/CC0 Public Domain A nationwide study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2 has found…
FDA approved of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin indicated along with diet and exercise to control high blood sugar in adults with type 2 diabetes. With FDA’s…
By Dennis Thompson HealthDay ReporterTHURSDAY, Sept. 24, 2026 (HealthDay News) — Add cancer to the list of health problems that can plague people with type 2 diabetes, a new study…
A new UIC study suggests that time-restricted eating could offer a safe and potentially effective way to improve blood sugar control in adults with Type 1 diabetes. The research was…
Type 1 diabetes affects more than 9 million people worldwide, including 1.8 million children and adolescents. While the disease is thought to be driven by complex genetic factors, researchers are…
September 17, 2026 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
VITAMIN D insufficiency is highly prevalent amongst children with Type 1 diabetes, despite many maintaining normal parathyroid hormone and calcium levels, new research from the United Arab Emirates has found.…
September 23, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…